Josh Nebo
EA7 Emporio Armani Milan
OUT
Injury Thigh
Est. Return 11/7/2025
Sidelined until November
Nebo (thigh) is expected to miss "at least another two" weeks, according to Sportando Italia.
ANALYSIS
It was announced in early October that Nebo would be reevaluated in three weeks, and it turns out he will miss at least a couple more. As such, don't expect to see Nebo back on the court until sometime in November.
It was announced in early October that Nebo would be reevaluated in three weeks, and it turns out he will miss at least a couple more. As such, don't expect to see Nebo back on the court until sometime in November.
EuroLeague Per Game Stats
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
Game Log
2025
2024
2023
2022
2021
Game Log
Loading Game Log...
Advanced Stats
Loading Advanced Stats...
EA7 Emporio Armani Milan Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Out for three weeks
Nebo (thigh) "will be re-evaluated in three weeks," according to Milan's official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Plays through injury
Nebo played through a thigh injury in Thursday's loss to Partizan, according to Alessandro Maggi of Sportando.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Puts injuries in past
Nebo (thigh) recorded 18 points, 10 rebounds and two blocks in a friendly against Brescia on Sept. 13.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Will miss more time
Nebo (thigh) will miss more time, according to Milan's official website.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Drops out with injury
Nebo left Saturday's domestic game with "a muscle problem," according to Milan's official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.